Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.
2.

Pharmacology and physiology of stereotyped behavior.

Randrup A, Munkvad I.

J Psychiatr Res. 1974;11:1-10. Review. No abstract available.

PMID:
4218871
3.

Pharmacological studies with some newly synthesized phenothiazines exhibiting lesser extrapyramidal reactions.

Sharma VN, Mital RL, Banerjee SP, Sharma HL.

Jpn J Pharmacol. 1969 Jun;19(2):211-23. No abstract available.

4.

Fluotracen: a tricyclic compound with the combined properties of antidepressants and antipsychotics in animals.

Fowler PJ, Zirkle CL, Macko E, Setler PE, Sarau HM, Misher A, Tedeschi DH.

Arzneimittelforschung. 1977;27(8):1589-95. No abstract available.

PMID:
410422
5.

Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system.

Sieroslawska J, Hano J, Sypniewska M, Czarnecki R, Chojnacka-Wójcik E, Harasiewicz A.

Pol J Pharmacol Pharm. 1973 Jan-Feb;25(1):1-16. No abstract available.

PMID:
4798097
6.

Behavioural correlates to the dopamine D-1 and D-2 antagonists.

Christensen AV, Arnt J, Hyttel J, Svendsen O.

Pol J Pharmacol Pharm. 1984 Mar-Jun;36(2-3):249-64.

PMID:
6147830
7.

2-(2-ethoxyphenoxymethyl)tetrahydro-1,4-oxazine hydrochloride, a potential psychotropic agent.

Mallion KB, Todd AH, Turner RW, Bainbridge JG, Greenwood DT, Madinaveitia J, Somerville AR, Whittle BA.

Nature. 1972 Jul 21;238(5360):157-8. No abstract available.

PMID:
4558457
8.

Some basic ketones with central nervous system depressant activity.

Harper NJ, Simmonds AB, Wakama WT, Hall GH, Vallance DK.

J Pharm Pharmacol. 1966 Mar;18(3):150-60. No abstract available.

PMID:
4381211
9.

Neuroleptic phenothiazines with 1,4-diazabicyclo-[4.4.0]decane and-[4.3.0]nonane Ring System.

Casagrande C, Galli A, Ferrini R, Miragoli G.

Arzneimittelforschung. 1971 Jun;21(6):808-11. No abstract available.

PMID:
4104913
10.

Analogs of phenothiazines. 5. Synthesis and neuropharmacological activity of some piperidylidene derivatives of thioxanthenes, xanthenes, dibenzoxepins, and acridans.

Kaiser C, Fowler PJ, Tedeschi DH, Lester BM, Garvey E, Zirkle CL.

J Med Chem. 1974 Jan;17(1):57-62. No abstract available.

PMID:
4808470
11.
12.

Caerulein and its analogues: neuropharmacological properties.

Zetler G.

Peptides. 1985;6 Suppl 3:33-46. Review.

PMID:
3913910
13.

Definition and classification of neuroleptics.

Arnold OH, Collard J, Deniker P, Ginestet D, Hippius H, Itil TM, Labhardt F, Leeds AA, Montanini R, Morozov G, Simon P, Villeneuve A.

Mod Probl Pharmacopsychiatry. 1970;5:141-7. No abstract available.

PMID:
5527163
14.

Iprindole-amphetamine interactions in the rat: the role of aromatic hydroxylation of amphetamine in its mode of action.

Freeman JJ, Sulser F.

J Pharmacol Exp Ther. 1972 Nov;183(2):307-15. No abstract available.

PMID:
4673401
15.

Pharmacological profile of the dopamine partial agonist, (+/-)-PD 128483 and its enantiomers.

Meltzer LT, Caprathe BW, Christoffersen CL, Corbin AE, Jaen JC, Ninteman FW, Pugsley TA, Serpa KA, Shih YH, Whetzel SZ, et al.

J Pharmacol Exp Ther. 1993 Sep;266(3):1177-89.

PMID:
8103791
16.

The neuroleptics. 3. Pharmacology. Introduction.

Van Rossum JM, Janssen PA, Boissier JR, Julou L, Loew DM, Moller Nielsen I, Munkvad I, Randrup A, Stille G, Tedeschi DH.

Mod Probl Pharmacopsychiatry. 1970;5:23-32. No abstract available.

PMID:
5527165
17.

The comparative pharmacology of flupenthixol and some reference neuroleptics.

Nielsen IM, Pedersen V, Nymark M, Franck KF, Boeck V, Fjalland B, Christensen AV.

Acta Pharmacol Toxicol (Copenh). 1973;33(5):353-62. No abstract available.

PMID:
4801081
18.

Actions of dopaminergic antagonists in the striatum.

Sedvall G, Fyrö B, Nybäck H, Wiesel FA.

Adv Neurol. 1975;9:131-40. No abstract available.

PMID:
238375
19.

[Contribution to the pharmacology of a novel neuroleptic drug: flupenthixol (author's transl)].

van den Driessche J.

Arzneimittelforschung. 1977;27(11):2121-5. German.

PMID:
580012
20.

Analogs of phenothiazines. 4. Effect of structure upon neuropharmacological activity of some chlorpromazine analogs of the diphenylmethane type.

Kaiser C, Pavloff AM, Garvey E, Fowler PJ, Tedeschi DH, Zirkle CL, Nodiff EA, Saggiomo AJ.

J Med Chem. 1972 Jun;15(6):665-73. No abstract available.

PMID:
5063998
Items per page

Supplemental Content

Support Center